Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss.
<h4>Background</h4>In case of early pregnancy loss (EPL) women can either choose for expectant, medical or surgical management. One week of expectant management is known to lead to spontaneous abortion in approximately 50% of women. Medical treatment with misoprostol is known to be safe...
Saved in:
Main Authors: | Charlotte C Hamel, Marcus P L M Snijders, Sjors F P J Coppus, Frank P H A Vandenbussche, Didi D M Braat, Eddy M M Adang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0262894&type=printable |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of the misoprostol for the abortion in the first trimester of the pregnancy in adolescents.
by: Práxedes Rojas Quintana, et al.
Published: (2008-04-01) -
Complete Cervical Avulsion with Intravaginal Misoprostol for Second Trimester Pregnancy Termination
by: G. R. Sajjan, et al.
Published: (2012-01-01) -
A Randomized Controlled Trial of Misoprostol and Sulprostone to End Pregnancy after Fetal Death
by: Kristin Van Mensel, et al.
Published: (2009-01-01) -
The effect of oxytocin, sublingual, and intrauterine misoprostol on blood loss in cesarean delivery: A randomized clinical trial
by: Mahdieh Masoumzadeh, et al.
Published: (2025-03-01) -
A disproportionality analysis of FDA adverse event reporting system events for misoprostol
by: Li Yang, et al.
Published: (2025-01-01)